Lenmeldy
Payments companies reported to CMS as associated with Lenmeldy. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lenmeldy, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lenmeldy
These are the largest totals companies reported as associated with Lenmeldy. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Lisa Emrick | Houston, TX | Pediatrics | $8,176.43 |
| Laura Adang | Philadelphia, PA | Child & Adolescent Psychiatry | $6,157.76 |
| Paul Orchard | Minneapolis, MN | Pediatric Hematology-Oncology | $6,011.02 |
| Barbara Burton | Chicago, IL | Clinical Genetics (M.D.) | $5,057.09 |
| Jennifer Harmon | Winston Salem, NC | Neurology With Special Qualifications In Child Neurology | $3,294.83 |
| Sandhya Kharbanda | San Francisco, CA | Pediatric Hematology-Oncology | $2,835.21 |
| Suhag Parikh | Atlanta, GA | Pediatrics | $2,558.57 |
| Jennifer Braun | North St Paul, MN | Family | $2,359.10 |
| Elizabeth Jalazo | Chapel Hill, NC | Pediatrics | $2,039.00 |
| Jennifer Rubin | Chicago, IL | Pediatrics | $1,247.00 |
Prescribed Lenmeldy?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.